Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Chemoradiotherapy in Stage IIIB NSCLC
NCT00030810Phase 2Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Sep 2001
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin in non-small cell lung cancer (NSCLC), sponsored by Swiss Group for Clinical Cancer Research. Started Sep 2001; status: completed.
02
Drugs
docetaxelcisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00030810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030810.